摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine | 1351-62-8

中文名称
——
中文别名
——
英文名称
N-Methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine
英文别名
——
N-Methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine化学式
CAS
1351-62-8
化学式
C8H14N2O
mdl
——
分子量
154.21
InChiKey
OPMNROCQHKJDAQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    24.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Croos-B Structure Binding Compounds
    申请人:Gebbink Martijn Frans Ben Gerard
    公开号:US20080267948A1
    公开(公告)日:2008-10-30
    The invention relates to the field of biochemistry, biophysical chemistry, molecular biology, structural biology and medicine. More in particular, the invention relates to cross-β structure conformation. Even more particular, the invention relates to compounds capable of binding to a compound with cross-β structure conformation, i.e. cross-β structure binding compounds and uses thereof.
    本发明涉及生物化学、生物物理化学、分子生物学、结构生物学和医学领域。更具体地说,本发明涉及交叉β结构构象。更具体地说,本发明涉及能够结合具有交叉β结构构象的化合物的化合物,即交叉β结构结合化合物及其用途。
  • Endophytes and related methods
    申请人:Agriculture Victoria Services PTY LTD
    公开号:US20170118943A1
    公开(公告)日:2017-05-04
    The present invention relates to a method for identifying and/or characterising an endophyte strain, said method including providing a plurality of samples of endophytes, subjecting said endophytes to genetic analysis, subjecting said endophytes to metabolic analysis and selecting endophytes having a desired genetic and metabolic profile. The present invention also relates to novel endophytes having a desired toxin profile wherein the endophyte produces significantly less toxic alkaloids compared with a control endophyte such as standard toxic (ST) endophyte; and/or significantly more alkaloids conferring beneficial properties compared with a control endophyte such as ST endophyte. The present invention also relates to endophyte variants having a desired genetic and metabolic profile, wherein said endophyte variants possess genetic and/or metabolic characteristics that result in a beneficial phenotype in a plant harbouring or otherwise associated with the endophyte variant. Preferably said endophyte variants are generated by polyploidisation or induced chromosome doubling.
  • Alkaloid-Containing Compositions and Uses Thereof
    申请人:Biotelliga Holdings Limited
    公开号:US20200199139A1
    公开(公告)日:2020-06-25
    The present invention provides compositions comprising loline alkaloids including pesticidal compositions, methods of producing the compositions and uses of the compositions including uses as control agents. Methods for the control of pests, including plant or animal pests, for the enhancement of plant growth or reproduction, and treatment and prevention of insect infection and infestation, for example in plants or animals, are also provided.
查看更多

同类化合物

N-甲酰基黑麦草碱 N-((2R,3S,3aS,4S,6aS)-六氢-2,4-甲桥-4H-呋喃并(3,2-b)吡咯-3-基)-N-甲基-乙酰胺 temuline carbamate N-acetylnorloline N-Formyl-norlolin Norlolin N-Acetyl-festucin Festucin (1S,6R,7R,7aS)-7-Azidohexahydro-1H-1,6-epoxypyrrolizine N-methylloline N-formylloline Lolin, Festucin loline N-Boc-norloline (+)-Loline dihydrochloride norloline (+)-Loline N-methyl-N-[(1R,3R,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]formamide (1R,3R,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine N-[(1R,3R,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]acetamide (1R,3R,7S,8R)-N,N-dimethyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine (1R,3R,7S,8R)-N-methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine Loline dihydrochloride (1R,3S)-N-methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine N-methyl-N-[(1R,3S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]formamide N-methyl-N-[(1S,3S,7S,8S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]cyclopropanecarboxamide N-methyl-N-[(1S,3S,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]cyclopropanecarboxamide N-methyl-N-[(1S,3S,7S,8S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]acetamide (1R,3R,7R,8S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine N-[(1S,3S,7S,8S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]acetamide N-methyl-N-[(1R,3S,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]cyclopropanecarboxamide (1S,3S,7S,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine (1R,3S,7R,8R)-N-Methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine (1S,3R,7S,8S)-N-methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine (+/-)-acetylnorloline (1S,3R,8S)-N-Methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine (1R,3R,7R,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine N-methyl-N-[(1S,3R,8S)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]cyclopropanecarboxamide N-methyl-N-[(1R,3R,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]nonanamide (1S,3R,7R,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine Methyl(2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl)azanium N-(2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl)acetamide N-methyl-N-(2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl)acetamide 2-Oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-ylazanium (1S,3R,7R,8R)-N-methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine N-Cyclopropanoyl loline N,3-dimethyl-N-[(1R,3R,8R)-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-yl]but-2-enamide [(1S,3R,7R,8R)-2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl]azanium [(1S,3R,7R,8S)-2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl]azanium N-methyl-N-[(1S,3R,7R,8S)-2-oxa-6-azoniatricyclo[4.2.1.03,7]nonan-8-yl]acetamide